The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Lipid Profiles in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?
Open accessAbstract
Levels of triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), and high-density lipoprotein cholesterol (HDL-c), as well as the TC:HDL-c ratio, were compared in patients receiving different antiretroviral therapy regimens. Patients receiving first-line regimens including protease inhibitors (PIs) had higher TC and TG levels and TC : HDL-c ratios than did antiretroviral-naive patients; patients receiving 2 PIs had higher levels of each lipid. Ritonavir-containing regimens were associated with higher TC and TG levels and TC : HDL-c ratios than were indinavir-containing regimens; however, receipt of nelfinavir was associated with reduced risk of lower HDL-c levels, and receipt of saquinavir was associated with lower TC : HDL-c ratios. Patients receiving nonnucleoside reverse-transcriptase inhibitors had higher levels of TC and LDL-c than did antiretroviral-naive patients, although the risk of having lower HDL-c levels was lower than that in patients receiving a single PI. Efavirenz was associated with higher levels of TC and TG than was nevirapine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Castro, K. G., Ward, J. W., Slutsker, L., Buehler, J. W., Jaffe, H. W., Berkelman, R. L., & Curran, J. W. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.4.802 · Cited by 4,349
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Carr, A., Samaras, K., Burton, S., Law, M., Freund, J., Chisholm, D. J., & Cooper, D. A. (1998) · AIDS · doi:10.1097/00002030-199807000-00003 · Cited by 2,370
Chambless, L. E., Heiss, G., Folsom, A. R., Rosamond, W., Szklo, M., Sharrett, A. R., & Clegg, L. X. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009302 · Cited by 1,990
Atherosclerosis: Basic Mechanisms: Oxidation, Inflammation, and Genetics
Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995) · Circulation · doi:10.1161/01.cir.91.9.2488 · Cited by 1,701
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa030218 · Cited by 1,678
Carr, A., Samaras, K., Thorisdottir, A., Kaufmann, G. R., Chisholm, D. J., & Cooper, D. A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08468-2 · Cited by 1,495
Friis-Møller, N., Weber, R., Reiss, P., Thiébaut, R., Kirk, O., Monforte, A. D., Pradier, C., Morfeldt, L., Mateu, S., Law, M., et al. (2003) · AIDS · doi:10.1097/00002030-200305230-00010 · Cited by 1,077
Self-citationAdverse effects of antiretroviral therapy
Carr, A., & Cooper, D. A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02854-3 · Cited by 1,057
Sharrett, A. R., Ballantyne, C. M., Coady, S. A., Heiss, G., Sorlie, P. D., Catellier, D., & Patsch, W. (2001) · Circulation · doi:10.1161/hc3501.095214 · Cited by 944
Flexner, C. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381808 · Cited by 852
Grunfeld, C. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.5.1045 · Cited by 848
Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection
Walmsley, S., Bernstein, B., King, M., Arribas, J., Beall, G., Ruane, P., Johnson, M., Johnson, D., Lalonde, R., Japour, A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012354 · Cited by 647
Bozzette, S. A., Ake, C. F., Tam, H. K., Chang, S. W., & Louis, T. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022048 · Cited by 625
Impact of HIV infection and HAART on serum lipids in men
Riddler, S. A. (2003) · JAMA · doi:10.1001/jama.289.22.2978 · Cited by 624
Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors
Périard, D., Telenti, A., Sudre, P., Cheseaux, J.-J., Halfon, P., Reymond, M. J., Marcovina, S. M., Glauser, M. P., Nicod, P., Darioli, R., et al. (1999) · Circulation · doi:10.1161/01.cir.100.7.700 · Cited by 605
Mary-Krause, M., Cotte, L., Simon, A., Partisani, M., & Costagliola, D. (2003) · AIDS · doi:10.1097/00002030-200311210-00010 · Cited by 564
Cholesterol and Coronary Heart Disease: Predicting Risks by Levels and Ratios
Kinosian, B., Glick, H., & Garland, G. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-9-199411010-00002 · Cited by 519
Behrens, G., Dejam, A., Schmidt, H., Balks, H.-J., Brabant, G., Körner, T., Stoll, M., & Schmidt, R. E. (1999) · AIDS · doi:10.1097/00002030-199907090-00001 · Cited by 515
Severe premature coronary artery disease with protease inhibitors
Henry, K., Melroe, H., Huebsch, J., Hermundson, J., Levine, C., Swensen, L., & Daley, J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79053-x · Cited by 513
Lemieux, I., Lamarche, B., Couillard, C., Pascot, A., Cantin, B., Bergeron, J., Dagenais, G. R., & Després, J.-P. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.22.2685 · Cited by 488
Stein, J. H., Klein, M. A., Bellehumeur, J. L., McBride, P. E., Wiebe, D. A., Otvos, J. D., & Sosman, J. M. (2001) · Circulation · doi:10.1161/01.cir.104.3.257 · Cited by 479
Tsiodras, S., Mantzoros, C., Hammer, S., & Samore, M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.13.2050 · Cited by 452
Postprandial plasma lipoprotein changes in human subjects of different ages.
Cohn, J. S., McNamara, J. R., Cohn, S. D., Ordovas, J. M., & Schaefer, E. J. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38520-5 · Cited by 446
Klein, D., Hurley, L. B., Quesenberry, C. P., & Sidney, S. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200208150-00002 · Cited by 420
Boden, W. E. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01464-8 · Cited by 396
Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine
Martínez, E., Conget, I., Lozano, L., Casamitjana, R., & Gatell, J. M. (1999) · AIDS · doi:10.1097/00002030-199905070-00009 · Cited by 321
van der Valk, M., Kastelein, J. J. P., Murphy, R. L., van Leth, F., Katlama, C., Horban, A., Glesby, M., Behrens, G., Clotet, B., Stellato, R. K., et al. (2001) · AIDS · doi:10.1097/00002030-200112070-00008 · Cited by 253
Self-citationSaquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-infected patients
Merry, C., Barry, M. G., Mulcahy, F., Halifax, K. L., & Back, D. J. (1997) · AIDS · doi:10.1097/00002030-199715000-00001 · Cited by 228
Ruiz, L., Negredo, E., Domingo, P., Paredes, R., Francia, E., Balagué, M., Gel, S., Bonjoch, A., Fumaz, C. R., Johnston, S., et al. (2001) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200107010-00003 · Cited by 174
Plasma lipids in HIV‐infected patients: a prospective study in 95 patients
CONSTANS, J., PELLEGRIN, J. L., PEUCHANT, E., DUMON, M. F., PELLEGRIN, I., SERGEANT, C., SIMONOFF, M., BROSSARD, G., BARBEAU, P., FLEURY, H., et al. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02185.x · Cited by 172
Negredo, E., Cruz, L., Paredes, R., Ruiz, L., Fumaz, C. R., Bonjoch, A., Gel, S., Tuldrà, A., Balagué, M., Johnston, S. S., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/324629 · Cited by 170
Epidemiologic aspects of lipid abnormalities
Criqui, M. H., & Golomb, B. A. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00212-5 · Cited by 158
Metabolic complications associated with antiretroviral therapy
Jain, R. G., Furfine, E. S., Pedneault, L., White, A. J., & Lenhard, J. M. (2001) · Antiviral Research · doi:10.1016/s0166-3542(01)00148-6 · Cited by 151
Seminari, E. M., Pan, A., Voltini, G., Carnevale, G., Maserati, R., Minoli, L., Meneghetti, G., Tinelli, C., & Testa, S. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00736-5 · Cited by 127
Mantel-Teeuwisse, A. K., Kloosterman, J. M. E., der Zee, A. H. M., Klungel, O. H., Porsius, A. J., & de Boer, A. (2001) · Drug Safety · doi:10.2165/00002018-200124060-00003 · Cited by 127
Mercié, P., Thiébaut, R., Aurillac-Lavignolle, V., Pellegrin, J., Yvorra-Vives, M. C., Morlat, P., Ragnaud, J., Dupon, M., Malvy, D. J.-M., Bellet, H., et al. (2002) · Annals of Medicine · doi:10.1080/078538902317338652 · Cited by 127
Self-citationBurchfiel, C. M., Laws, A., Benfante, R., Goldberg, R. J., Hwang, L., Chiu, D., Rodríguez, B. L., Curb, J. D., & Sharp, D. S. (1995) · Circulation · doi:10.1161/01.cir.92.6.1430 · Cited by 78
Carotid intima-media thickness and coronary heart disease risk factors in a low-risk population
Ferrières, J., Élias, A., Ruidavets, J., Cantet, C., Bongard, V., Fauvel, J., & Boccalon, H. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917060-00004 · Cited by 77
Metabolic Disorders Among HIV-Infected Patients Treated With Protease Inhibitors: A Review
Graham, N. M. H. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200010001-00002 · Cited by 73
Hyperlipidemia under treatment with proteinase inhibitors
Segerer, S., Bogner, J. R., Walli, R., Loch, O., & Goebel, F. D. (1999) · Infection · doi:10.1007/bf02560501 · Cited by 69
Lundgren, J. D., Phillips, A. N., Vella, S., Katlama, C., Ledergerber, B., Johnson, A. M., Reiss, P., Gatell, J. M., Clumeck, N., Dietrich, M., et al. (1997) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199711010-00003 · Cited by 61
Self-citationThiébaut, R., Dabis, F., Malvy, D. J.-M., Jacqmin‐Gadda, H., Mercié, P., & Valentin, V. D. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200003010-00009 · Cited by 52
Bonnet, F., s, M. S., Droz‐Perroteau, C., Peuchant, E., Ch??ne, G., Beylot, J., & Morlat, P. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200010010-00017 · Cited by 34
Highly active antiretroviral therapy and coronary heart disease: the need for perspective
Egger, M., Junghans, C., Friis‐Møller, N., & Lundgren, J. D. (2001) · AIDS · doi:10.1097/00002030-200100005-00023 · Cited by 30
Self-citationMatthews, G. V., Moyle, G. J., Mandalia, S., Bower, M., Nelson, M. R., & Gazzard, B. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200008010-00002 · Cited by 30
Cardiovascular Disease Risk Factors in HIV‐Infected Patients in the HAART Era
Galli, M., Ridolfo, A. L., & Gervasoni, C. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03913.x · Cited by 21
Cited by
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
Aberg, J. A., Kaplan, J. E., Libman, H., Emmanuel, P., Anderson, J. R., Stone, V. E., Oleske, J. M., Currier, J. S., & Gallant, J. E. (2009) · Clinical Infectious Diseases · doi:10.1086/605292 · Cited by 837
Worm, S. W., Sabin, C., Weber, R., Reiss, P., El‐Sadr, W., Dabis, F., De Wit, S., Law, M., Monforte, A. D., Friis‐Møller, N., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/649897 · Cited by 648
Self-citationvan Leth, F., Phanuphak, P., Stroes, E., Gazzard, B., Cahn, P., Raffi, F., Wood, R., Bloch, M., Katlama, C., Kastelein, J. J. P., et al. (2004) · PLoS Medicine · doi:10.1371/journal.pmed.0010019 · Cited by 276
Self-citation
Metadata
- Authors
- Fontas, E., van Leth, F., Sabin, C. A., Friis‐Møller, N., Rickenbach, M., d’Arminio Monforte, A., Kirk, O., Dupon, M., Morfeldt, L., Mateu, S., Petoumenos, K., El‐Sadr, W., de Wit, S., Lundgren, J. D., Pradier, C., Reiss, P., & D:A:D Study Group
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-03-15
- Volume
- 189
- Issue
- 6
- Pages
- 1056-1074
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2159584933
- Cited by
- 337
- References
- 51
- FWCI
- 37.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.